BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14512412)

  • 21. Chemoradiotherapy in high-grade gliomas.
    Ulutin C
    Tumori; 2007; 93(5):526; author reply 526. PubMed ID: 18038893
    [No Abstract]   [Full Text] [Related]  

  • 22. Temozolomide for refractory anaplastic astrocytoma.
    Med Lett Drugs Ther; 1999 Dec; 41(1068):123-4. PubMed ID: 10987014
    [No Abstract]   [Full Text] [Related]  

  • 23. Temozolomide and radiation in low-grade and anaplastic gliomas: temoradiation.
    Schiff D
    Cancer Invest; 2007 Dec; 25(8):776-84. PubMed ID: 17952745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients.
    Brandes AA; Franceschi E; Tosoni A; Blatt V; Pession A; Tallini G; Bertorelle R; Bartolini S; Calbucci F; Andreoli A; Frezza G; Leonardi M; Spagnolli F; Ermani M
    J Clin Oncol; 2008 May; 26(13):2192-7. PubMed ID: 18445844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central neurotoxicity of standard treatment in patients with newly-diagnosed high-grade glioma: a prospective longitudinal study.
    Froklage FE; Oosterbaan LJ; Sizoo EM; de Groot M; Bosma I; Sanchez E; Douw L; Heimans JJ; Reijneveld JC; Lagerwaard FJ; Buter J; Uitdehaag BM; Klein M; Postma TJ
    J Neurooncol; 2014 Jan; 116(2):387-94. PubMed ID: 24264531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival of human glioma cells treated with various combination of temozolomide and X-rays.
    van Rijn J; Heimans JJ; van den Berg J; van der Valk P; Slotman BJ
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):779-84. PubMed ID: 10837964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The inhibition of proliferation and migration of glioma spheroids exposed to temozolomide is less than additive if combined with irradiation.
    Fehlauer F; Muench M; Richter E; Rades D
    Oncol Rep; 2007 Apr; 17(4):941-5. PubMed ID: 17342340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of temozolomide in malignant brain tumours.
    Osoba D
    Lancet; 2000 Jul; 356(9226):342. PubMed ID: 11071219
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment-related myelodysplastic syndrome after temozolomide use in a child: first report.
    Dufour C; Da Costa L; Auger N; Jullien M; Bhangoo R; Grill J
    J Pediatr Hematol Oncol; 2008 Nov; 30(11):857-9. PubMed ID: 18989164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temozolomide chemotherapy in patients with recurrent malignant gliomas.
    Yang SH; Kim MK; Lee TK; Lee KS; Jeun SS; Park CK; Kang JK; Kim MC; Hong YK
    J Korean Med Sci; 2006 Aug; 21(4):739-44. PubMed ID: 16891823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Australian experience with temozolomide for the treatment of recurrent high grade gliomas.
    Harris MT; Rosenthal MA; Ashley DL; Cher L
    J Clin Neurosci; 2001 Jul; 8(4):325-7. PubMed ID: 11437571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas.
    Glantz M; Chamberlain M; Liu Q; Litofsky NS; Recht LD
    Cancer; 2003 May; 97(9):2262-6. PubMed ID: 12712481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defining the standard of care for high-grade glioma--a NICE deal for UK patients?
    Khanduri S; Gerrard G
    Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):507-8. PubMed ID: 17618095
    [No Abstract]   [Full Text] [Related]  

  • 34. Temozolomide treatment in glioma--experiences in two university hospitals in Finland.
    Mäenpää HO; Aaltonen K; Mäntylä R; Minn H
    Acta Oncol; 2004; 43(6):579-84. PubMed ID: 15370616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temozolomide in the treatment of recurrent malignant glioma in Chinese patients.
    Chan DT; Poon WS; Chan YL; Ng HK
    Hong Kong Med J; 2005 Dec; 11(6):452-6. PubMed ID: 16340021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The economics of temozolomide in brain cancer.
    Crott R
    Expert Opin Pharmacother; 2007 Aug; 8(12):1923-9. PubMed ID: 17696793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Central nervous system glioma. Multi-drug chemotherapy including temozolomide].
    Wakabayashi T
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):938-40. PubMed ID: 19579330
    [No Abstract]   [Full Text] [Related]  

  • 38. Temozolomide in malignant gliomas.
    Yung WK
    Semin Oncol; 2000 Jun; 27(3 Suppl 6):27-34. PubMed ID: 10866347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas.
    Gerber DE; Grossman SA; Zeltzman M; Parisi MA; Kleinberg L
    Neuro Oncol; 2007 Jan; 9(1):47-52. PubMed ID: 17108062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current and future developments in the use of temozolomide for the treatment of brain tumours.
    Stupp R; Gander M; Leyvraz S; Newlands E
    Lancet Oncol; 2001 Sep; 2(9):552-60. PubMed ID: 11905710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.